PDL Biopharma v. Genentech [Premium]

CONCLUDED

Hearing
04/21/11 – 04/21/11

Summary

In this Pharmaceutical Intellectual Property litigation hearing, Plaintiff PDL Biopharma sought to compel Hoffman La Roche Inc to continue paying royalties for certain drugs that infringe upon the plaintiff’s biotechnology patents. Plaintiff’s counsels argued that Roche and its subsidiary Genentech were not paying the pre-decided royalties to PDL Biopharma.

The plaintiff was represented by attorney PDL Biopharma Inc was represented by attorney David Gindler. The defendant in this case Hoffman La Roche Inc was represented by attorney Evan Chasler.

Sessions

Recording Disclaimer: This proceeding was recorded in full.

AudioCaseFiles

Exclusive audio opinions to enhance your law school experience

AudioCaseFiles

Essentials

The most important and informative moments of each trial

Essentials

Training Libraries

Trial Advocacy, Rules of Evidence and Appellate Advocacy

Training

  • Follow Us